BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortega JT, Jastrzebska B, Rangel HR. Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis. Pathogens 2021;11:45. [PMID: 35055993 DOI: 10.3390/pathogens11010045] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim S, Liu Y, Ziarnik M, Seo S, Cao Y, Zhang XF, Im W. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS‐CoV ‐2 variants of concern. J Comput Chem 2022. [DOI: 10.1002/jcc.27025] [Reference Citation Analysis]
2 Esper FP, Adhikari TM, Tu ZJ, Cheng Y, El-haddad K, Farkas DH, Bosler D, Rhoads D, Procop GW, Ko JS, Jehi L, Li J, Rubin BP. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants. The Journal of Infectious Diseases 2022. [DOI: 10.1093/infdis/jiac411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Barh D, Tiwari S, Rodrigues Gomes LG, Ramalho Pinto CH, Andrade BS, Ahmad S, Aljabali AAA, Alzahrani KJ, Banjer HJ, Hassan SS, Redwan EM, Raza K, Góes-Neto A, Sabino-Silva R, Lundstrom K, Uversky VN, Azevedo V, Tambuwala MM. SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach. Inflammation 2022. [PMID: 36215001 DOI: 10.1007/s10753-022-01734-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ching WY, Adhikari P, Jawad B, Podgornik R. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex. Int J Mol Sci 2022;23:10091. [PMID: 36077490 DOI: 10.3390/ijms231710091] [Reference Citation Analysis]
5 Wang T, Cao Y, Zhang H, Wang Z, Man CH, Yang Y, Chen L, Xu S, Yan X, Zheng Q, Wang YP. COVID-19 metabolism: Mechanisms and therapeutic targets. MedComm (2020) 2022;3:e157. [PMID: 35958432 DOI: 10.1002/mco2.157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zambrano JL, Jaspe R, Hidalgo M, Sulbarán Y, Loureiro C, Moros Z, Garzaro D, Vizzi E, Rangel H, Liprandi F, Pujol F. Sub-lineages of the Omicron variant of SARS-CoV-2: characteristic mutations and their relation to epidemiological behavior. Investigación Clínica 2022;63:262-274. [DOI: 10.54817/ic.v63n3a05] [Reference Citation Analysis]
7 Solanki K, Rajpoot S, Kumar A, J Zhang KY, Ohishi T, Hirani N, Wadhonkar K, Patidar P, Pan Q, Baig MS. Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations. Future Virology. [DOI: 10.2217/fvl-2022-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ching W, Adhikari P, Jawad B, Podgornik R. Effect of Delta and Omicron mutations on the RBD-SD1 domain of the Spike protein in SARS-CoV-2 and the Omicron mutations on RBD-ACE2 interface complex.. [DOI: 10.1101/2022.07.28.501901] [Reference Citation Analysis]
9 D’arminio N, Giordano D, Scafuri B, Biancaniello C, Petrillo M, Facchiano A, Marabotti A. In Silico Analysis of the Effects of Omicron Spike Amino Acid Changes on the Interactions with Human Proteins. Molecules 2022;27:4827. [DOI: 10.3390/molecules27154827] [Reference Citation Analysis]
10 Fazekas Z, Menyhárd DK, Perczel A. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2. J Chem Inf Model 2022. [PMID: 35849759 DOI: 10.1021/acs.jcim.2c00397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Giron CC, Laaksonen A, Barroso da Silva FL. Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2095305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Khan A, Khan SA, Zia K, Altowyan MS, Barakat A, Ul-Haq Z. Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor. Front Chem 2022;10:892093. [PMID: 35755247 DOI: 10.3389/fchem.2022.892093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ghimire D, Han Y, Lu M. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants. Viruses 2022;14:1255. [PMID: 35746726 DOI: 10.3390/v14061255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
14 Silva SJRD, Kohl A, Pena L, Pardee K. Recent insights into SARS-CoV-2 omicron variant. Rev Med Virol 2022;:e2373. [PMID: 35662313 DOI: 10.1002/rmv.2373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Acharjee A, Stephen Kingsly J, Kamat M, Kurlawala V, Chakraborty A, Vyas P, Vaishnav R, Srivastava S. Rise of the SARS-CoV-2 Variants: Can proteomics be the silver bullet? Expert Rev Proteomics 2022. [PMID: 35655386 DOI: 10.1080/14789450.2022.2085564] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hamdy ME, El-deeb AH, Hagag NM, Shahein MA, Alaidi O, Hussein HA. Mutations of the SARS-CoV-2 Spike Glycoprotein Detected in Cats and Their Effect on Its Structure and Function. Front Cell Infect Microbiol 2022;12:875123. [DOI: 10.3389/fcimb.2022.875123] [Reference Citation Analysis]
17 Yeryomenko G, Bezditko T, Ospanova T. THE VIEW OF THE CLINICIAN ON THE PROBLEM OF COVID-19: review. IC 2022;8:217-225. [DOI: 10.35339/ic.8.4.217-225] [Reference Citation Analysis]
18 Nan B, Zhang S, Li Y, Kang X, Chen Y, Li L, Jiang T, Li J. Convolutional Neural Networks Based on Sequential Spike Predict the High Human Adaptation of SARS-CoV-2 Omicron Variants. Viruses 2022;14:1072. [DOI: 10.3390/v14051072] [Reference Citation Analysis]
19 Scherer EM, Babiker A, Adelman MW, Allman B, Key A, Kleinhenz JM, Langsjoen RM, Nguyen P, Onyechi I, Sherman JD, Simon TW, Soloff H, Tarabay J, Varkey J, Webster AS, Weiskopf D, Weissman DB, Xu Y, Waggoner JJ, Koelle K, Rouphael N, Pouch SM, Piantadosi A. SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies.. [DOI: 10.1101/2022.04.12.22273675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Fedotova MS, Filippova AY, Omarov MA, Yurchenko KS, Gulyaeva MA. SARS‐CoV‐2: the prospects of the virus spreading and the course of the pathogenesis of coronavirus infection in various species of animals. Ûg Ross : èkol razvit 2022;17:6-16. [DOI: 10.18470/1992-1098-2022-1-6-16] [Reference Citation Analysis]
21 Baindara P, Roy D, Mandal SM, Schrum AG. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis. Infectious Disease Reports 2022;14:243-9. [DOI: 10.3390/idr14020029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Samanta A, Alam SSM, Ali S, Hoque M. Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant. EXCLI J 2022;21:610-20. [PMID: 35651657 DOI: 10.17179/excli2022-4721] [Reference Citation Analysis]
23 Zhang Y, Wu G, Chen S, Ju X, Yimaer W, Zhang W, Lin S, Hao Y, Gu J, Li J. A review on COVID-19 transmission, epidemiological features, prevention and vaccination. Medical Review 2022;2:23-49. [DOI: 10.1515/mr-2021-0023] [Reference Citation Analysis]
24 Barh D, Tiwari S, Gomes LGR, Pinto CHR, Andrade BS, Ahmad S, Aljabali AAA, Alzahrani KJ, Banjer HJ, Hassan SS, Tambuwala M, Redwan EM, Raza K, Azevedo V, Lundstrom K, Uversky VN. SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine spur, an increasing antigenic and antiinflammatory cytokine induction, and rising structural protein instability.. [DOI: 10.1101/2022.02.15.480592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Giron CC, Laaksonen A, da Silva FLB. Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies.. [DOI: 10.1101/2022.01.29.478316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kim S, Liu Y, Ziarnik M, Cao Y, Zhang XF, Im W. Binding of Human ACE2 and RBD of Omicron Enhanced by Unique Interaction Patterns Among SARS-CoV-2 Variants of Concern. bioRxiv 2022:2022. [PMID: 35118473 DOI: 10.1101/2022.01.24.477633] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]